Testing supplies are required to continue Newborn DNA Analysis testing as part of the Newborn Screening Program. Without these testing supplies, we…

The Texas Health and Human Services Commission (HHSTX) has awarded a contract to Fisher Scientific Company LLC for critical testing supplies essential to the state's Newborn Screening Program. The contract, identified by HHSTX-6-0000393217, focuses on providing laboratory consumables and chemicals (UNSPSC 41121822) for Newborn DNA Analysis testing. These supplies are crucial for conducting diagnostic screenings that enable early detection and treatment of potential disorders in newborns.

The contract, dated January 14, 2026, addresses a vital public health need by ensuring the continuation of comprehensive newborn testing capabilities. While specific contract value details are not provided, the procurement appears strategically important for preventing potential delays in diagnosis that could result in irreversible negative health impacts. The supplies fall under the NIGP code 17553 for Laboratory Equipment, General, and will support the Texas Health and Human Services Commission's ongoing efforts to maintain comprehensive newborn health screening protocols.